Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/02/2012 | US20120196924 METHODS AND PRODUCTS FOR EXPRESSION OF MICRO RNAs |
08/02/2012 | US20120196922 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency |
08/02/2012 | US20120196921 Modulation of sglt-2 expression |
08/02/2012 | US20120196920 Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases |
08/02/2012 | US20120196805 Compositions and methods to control angiogenesis with cupredoxins |
08/02/2012 | US20120196803 Fusion proteins for delivery of gdnf and bdnf to the central nervous system |
08/02/2012 | US20120196769 Methods of repairing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer |
08/02/2012 | US20120196760 Methods and compositions for identifying modulators of anti-tetherin activity to inhibit propagation of viruses |
08/02/2012 | US20120196372 Methods for Reducing Gluconoylation of Proteins |
08/02/2012 | US20120196371 Multi plasmids system for the production of influenza virus |
08/02/2012 | US20120196370 Methods and compositions for targeted genomic deletion |
08/02/2012 | US20120196360 Method of efficiently establishing induced pluripotent stem cells |
08/02/2012 | US20120196359 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF |
08/02/2012 | US20120196335 Ligf-type transformants for bioconversion of lignin-derived compounds |
08/02/2012 | US20120196327 Process for production of protein |
08/02/2012 | US20120196325 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
08/02/2012 | US20120196321 Selectable markers and related methods |
08/02/2012 | US20120196308 Methods and Kits for Measuring Von Willebrand Factor |
08/02/2012 | US20120196295 UV Excitable Fluorescent Energy Transfer Dyes |
08/02/2012 | US20120196278 Rna polyphosphatase compositions, kits, and uses thereof |
08/02/2012 | US20120195927 Gm-negative ehv-mutants without heterologous elements |
08/02/2012 | US20120195919 Hybrid and tandem expression of neisserial proteins |
08/02/2012 | US20120195912 Cripto Blocking Antibodies and Uses Thereof |
08/02/2012 | US20120195910 Anti-pcsk9 antibodies and methods of use |
08/02/2012 | US20120195909 Antibodies against a proliferating inducing ligand (april) |
08/02/2012 | US20120195905 Targeted binding agents directed to dll4 and uses thereof 524 |
08/02/2012 | US20120195904 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES |
08/02/2012 | US20120195901 Compositions and Methods for Binding Lysophosphatidic Acid |
08/02/2012 | US20120195900 Tri-variable domain binding proteins and uses thereof |
08/02/2012 | US20120195897 Human domain antibodies against components of the human insulin-like growth factor (igf) system |
08/02/2012 | US20120195895 Fusion Protein of an Anti-CD20 Antibody Fab Fragment and Lidamycin, a Method for Preparing the Same, and the Use Thereof |
08/02/2012 | US20120195883 Monocot seed product comprising a human blood protein |
08/02/2012 | US20120195882 lipoparticle comprising a protein and methods of making and using the same |
08/02/2012 | US20120195879 Carrier immunoglobulins and uses thereof |
08/02/2012 | US20120195874 Dfpase enzymes from aplysia californica |
08/02/2012 | US20120195872 Antimicrobial agents |
08/02/2012 | US20120195866 PKD Ligands and Polynucleotides Encoding PKD Ligands |
08/02/2012 | US20120195852 Vaccines, immunotherapeutics and methods for using the same |
08/02/2012 | US20120195829 Methods for identifying targeting domains and method and compositions comprising the same |
08/02/2012 | DE19919121B4 Multimeres CMV-Antigen The multimeric CMV antigen |
08/02/2012 | DE112010003032T5 Pflanzen mit erhöhtem Ertrag Plants with increased yield |
08/02/2012 | CA2825924A1 Respiratory metabolism-associated gene bnaox1 from brassica napus and use thereof |
08/02/2012 | CA2825789A1 Novel use of a dense and erect panicle 1 gene in improving nitrogen utilization efficiency |
08/02/2012 | CA2825722A1 Expression of soluble viral fusion glycoproteins in mammalian cells |
08/02/2012 | CA2825573A1 Humanized anit-egfr antibody l4-h3 and coding gene thereof |
08/02/2012 | CA2825552A1 Engineering of immunoglobulin domains |
08/02/2012 | CA2825549A1 Transgenic pig for mutant gucy2d as cone dystrophy model |
08/02/2012 | CA2825525A1 Compositions and methods for succinate production |
08/02/2012 | CA2825522A1 Methods of detecting lung cancer |
08/02/2012 | CA2825443A1 Method for the construction of specific promoters |
08/02/2012 | CA2825105A1 Thermostable chitosanase |
08/02/2012 | CA2825049A1 Novel bacillus thuringiensis genes with lepidopteran activity |
08/02/2012 | CA2823774A1 Inhibitors of branched-chain-aminotransferase-1 (bcat1) for the treatment of brain tumors |
08/02/2012 | CA2822953A1 Selective detection of haemophilus influenzae |
08/02/2012 | CA2821559A1 Oligonucleotide replacement for di-tagged and directional libraries |
08/01/2012 | EP2481810A1 A method for providing DNA fragments derived from a remote sample |
08/01/2012 | EP2481808A1 Amelioration of metabolic syndrome or method for screening for ameliorating agent for metabolic syndrome utilizing physiological function of sphingomyelin synthase sms2 |
08/01/2012 | EP2481804A1 Lentiviral vector comprising at least two TAR elements |
08/01/2012 | EP2481803A1 Molecules of nucleic acids coding a dextran-saccharase catalysing the synthesis of dextran having alpha-1,2 osidic branching |
08/01/2012 | EP2481802A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
08/01/2012 | EP2481801A1 Inhibitors of branched-chain-aminotransferase-1 (BCAT1) for the treatment of neoplasia |
08/01/2012 | EP2481800A2 Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof |
08/01/2012 | EP2481799A1 Method for transforming stramenopile |
08/01/2012 | EP2481798A1 Aspergillus non-inherited genetic variant having enhanced protease activity, and a production method for a natural flavour enhancer employing the same |
08/01/2012 | EP2481796A1 Glucoamylase variants |
08/01/2012 | EP2481793A2 Recombinant microorganism with increased butanol production ability, and preparation method of butanol using same |
08/01/2012 | EP2481791A1 Nucleic acid extraction method |
08/01/2012 | EP2481755A1 Antibody capable of recognizing hla class i |
08/01/2012 | EP2481754A1 Specific binding proteins and uses thereof |
08/01/2012 | EP2481752A1 Modified antibody constant regions |
08/01/2012 | EP2481287A1 Human skin equivalents expressing exogenous polypeptides |
08/01/2012 | EP2480689A1 Detection of target nucleic acid sequences by cyclic exonucleolytic reactions |
08/01/2012 | EP2480678A1 Stable production of lentiviral vectors |
08/01/2012 | EP2480677A1 Semi-stable production of lentiviral vectors |
08/01/2012 | EP2480676A1 Hybrid light chain mice |
08/01/2012 | EP2480675A1 Mice expressing alight chain with human lambda variable and mouse constant regions |
08/01/2012 | EP2480674A1 Plants having enhanced yield-related traits and a method for making the same |
08/01/2012 | EP2480673A1 Method for producing 3-hydroxypropionic acid and other products |
08/01/2012 | EP2480672A1 Novel chimeric polynucleotides and polypeptides enabling the secretion of a polypeptide of interest in combination with exosomes and uses thereof |
08/01/2012 | EP2480671A1 Process for producing molecules containing specialized glycan structures |
08/01/2012 | EP2480670A1 Cell imaging method for viewing microrna biogenesis in the cells |
08/01/2012 | EP2480669A2 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity |
08/01/2012 | EP2480668A2 Compositions and methods for silencing genes expressed in cancer |
08/01/2012 | EP2480667A1 Modulation of ttc39 expression to increase hdl |
08/01/2012 | EP2480666A1 Compositions, methods, and kits for isolating and analyzing nucleic acids using an anion exchange material |
08/01/2012 | EP2480665A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
08/01/2012 | EP2480658A1 Method of preparing plant-derived vlps |
08/01/2012 | EP2480650A1 Subtilase variants |
08/01/2012 | EP2480573A1 Treating cancer by modulating mex-3 |
08/01/2012 | EP2480566A1 Plants having enhanced yield-related traits and a method for making the same |
08/01/2012 | EP2480560A1 Method of preparing plant-derived proteins |
08/01/2012 | EP2281045B1 Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging |
08/01/2012 | EP2257624B9 Methods and compositions |
08/01/2012 | EP2194128B1 Compositions and methods for inhibiting expression of the PCSK9 gene |
08/01/2012 | EP2132319B1 Method for producing an antifungal peptide in a filamentous fungal host cell |
08/01/2012 | EP2004829B1 Plants having enhanced yield-related traits and a method for making the same |
08/01/2012 | EP1964916B1 Multi-purpose acylation catalayst and use thereof |
08/01/2012 | EP1921146B1 Recombinant vectors based on the modified ankara virus (mva) as preventive and therapeutic vaccines against aids |
08/01/2012 | EP1797183B1 Regulation of oncogenes by micrornas |
08/01/2012 | EP1766082B1 Cog47 protein and s100beta gene polymorphism |